<?xml version="1.0" encoding="UTF-8"?>
<results title="migration">
 <result pre=": Original Article: Original Articles miR‐15b enhances the proliferation and" exact="migration" post="of lung adenocarcinoma by targeting BCL2 miR‐15b promotes progression"/>
 <result pre="were conducted to measure the capacities of cell viability and" exact="migration" post="in SPC‐A1 cells. Luciferase assay was utilized to verifymiR‐15b"/>
 <result pre="improved LUAD growth in vitro and vivo. miR‐15b enhanced cell" exact="migration" post="and epithelial–mesenchymal transition (EMT) in LUAD. miR‐15b promoted cell"/>
 <result pre="and epithelial–mesenchymal transition (EMT) in LUAD. miR‐15b promoted cell viability," exact="migration" post="and EMT through inhibiting BCL2 expression by targeting to"/>
 <result pre="3′‐UTR. BCL2 reversed functions of miR‐15b on promoting cell proliferation," exact="migration" post="and EMT in SPC‐A1 cells. Conclusions miR‐15b promoted cell"/>
 <result pre="and EMT in SPC‐A1 cells. Conclusions miR‐15b promoted cell viability," exact="migration" post="and EMT by targeting BCL2 in LUAD. The newly"/>
 <result pre="healing assay A wound‐healing assay was used to evaluate the" exact="migration" post="ability. Briefly, SPC‐A1 cells were seeded into six‐well plates"/>
 <result pre="(c) () mimic NC, () miR‐15b mimic. MiR‐15b enhanced cell" exact="migration" post="and EMT in LUAD Transwell assay was used to"/>
 <result pre="in LUAD Transwell assay was used to measure the cell" exact="migration" post="after transfection of the miR‐15b mimic or the miR‐15b"/>
 <result pre="transfection of the miR‐15b mimic in APC‐A1 cells promoted cell" exact="migration" post="(P &amp;lt; 0.05), while miR‐15b inhibitor reduced cell migration (P &amp;lt; 0.05) (Fig"/>
 <result pre="cells promoted cell migration (P &amp;lt; 0.05), while miR‐15b inhibitor reduced cell" exact="migration" post="(P &amp;lt; 0.05) (Fig 3a). Wound healing assay was also used"/>
 <result pre="the metastasis of LUAD cells. Figure 3 MiR‐15b enhanced cell" exact="migration" post="and epithelial‐mesenchymal transition (EMT) in LUAD. (a) Transwell assay"/>
 <result pre="miR‐15b mimic promoted cell migration, while miR‐15b inhibitor reduced cell" exact="migration" post="in APC‐A1 cells. (b) Wound healing assay indicated that"/>
 <result pre="in APC‐A1 cells. (b) Wound healing assay indicated that cell" exact="migration" post="was regulated by miR‐15b in APC‐A1 cells. (c) MiR‐15b"/>
 <result pre="BCL2(+), () BCL2(−). Knockdown of BCL2 suppressed cell proliferation and" exact="migration" post="In SPC‐A1 cells, BCL2 was knocked down by siRNA‐BCL2"/>
 <result pre="knock down (P &amp;lt; 0.05) (Fig 6b). Transwell assay demonstrated that cell" exact="migration" post="was enhanced after interference of BCL2 (P &amp;lt; 0.05) (Fig 6c)."/>
 <result pre="6c). Wound healing assay indicated that knockdown BCL2 enhanced cell" exact="migration" post="(Fig 6d). Figure 6 Knockdown of BCL2 suppressed cell"/>
 <result pre="by knockdown of BCL2. (c) Transwell assay demonstrated that cell" exact="migration" post="was enhanced after interference of BCL2. (d) Wound healing"/>
 <result pre="(Fig 6b). Wound healing and Transwell assays revealed that cell" exact="migration" post="was increased after transfection with pcDNA3.1‐BCL2, versus cells only"/>
 <result pre="partially reversed the role of miR‐15b on LUAD cell proliferation," exact="migration" post="and EMT. Figure 7 BCL2 partially reversed the role"/>
 <result pre="proliferative ability was enhanced by overexpressing BCL2. (c, d) Cell" exact="migration" post="was increased after transfection of pcDNA3.1‐BCL2 versus cells only"/>
 <result pre="above. Downregulation of miR‐15b has been reported to inhibit cell" exact="migration" post="and metastasis in colorectal cancer.32 Similarly, in NSCLC, miR‐15b"/>
 <result pre="these results, and we determined that miR‐15b improved cell viability," exact="migration" post="and EMT in LUAD and miR‐15b enhanced LUAD cell"/>
 <result pre="addition, BCL2 reversed functions of miR‐15b on promoting cell proliferation," exact="migration" post="and EMT in SPC‐A1 cells. In conclusion, MiR‐15b was"/>
 <result pre="a worse outcome for LUAD patients. MiR‐15b promoted cell viability," exact="migration" post="and EMT through inhibiting BCL2 expression by targeting to"/>
 <result pre="BCL2 partially reversed functions of miR‐15b on promoting cell proliferation," exact="migration" post="and EMT in SPC‐A1 cells. MiR‐15b exerts carcinogenesis by"/>
 <result pre="(4): 1901–8.27499071 32LiJ, ChenY, GuoXet alInhibition of miR‐15b decreases cell" exact="migration" post="and metastasis in colorectal cancer. Tumour Biol2016; 37 (7):"/>
</results>
